Article Details
Retrieved on: 2025-02-12 12:33:33
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Moderna (MRNA), once a pandemic-era darling, has seen its stock plummet 65% over the past year, battered by fading vaccine demand and pipeline u.
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here